Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
07 October 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
MICT Seta Grant
The MICT SETA Journalism programme will give addition training to 20 Journalism students from the Department of Communication Science.

Student success is one of the key components in the Integrated Transformation Plan. Facilitated by a grant from the Media Information and Communication Technologies (MICT) SETA, the Department of Communication Science at the University of the Free State (UFS) is providing an additional training opportunity for its students with a programme for second-year journalism students. 

The MICT SETA Journalism Short Programme is a prestigious extracurricular opportunity. “The programme will provide additional exposure and training in specialist areas not necessarily covered in depth as part of the BA (Journalism) degree,” says Dr Willemien Marais, Programme Director: Communication Science. “Participation in this programme provides students the opportunity to build a portfolio to enhance their employability.” 

The SETA grant was acquired through an application made by the department with the assistance of Juanita Burjins Head: Leadership and Development Unit in the Human Resources Department at the UFS, and was signed earlier this year.

In-depth training 

The programme will entail short courses on writing, photojournalism, documentary filmmaking, entrepreneurship and personal development. 
“It gives us an opportunity to swim in an ocean where it feels you are drowning. I am very excited to have been chosen to be part of the programme,” says.Rene Robinson, a second-year Journalism student and one of 20 selected for the programme. They were selected based on academic performance as well as on the essay they wrote. 

Robinson says: “As a Journalism student you meet a lot of negativity about the degree you are pursuing and this programme offers a chance to elevate yourself.” 
Keamogetswe Mosepele, who is also part of the programme, adds: “I am really excited to see what it will deliver.” 

The programme specifically targets second-year students so these students, once in their final year, can share their experience through assisting a new cohort of first-year journalism students in various practical exercises, thus reinvesting in the department. They will also work at various media partners of the Department of Communication Science.

MICT Seta grant
From the left;  Nkonsinathi Gabuza, from the MICT Seta; Dr Willemien Marais; Prof Collin Chasi, Head of the Department Communication
 Science and Juanita Burjins. (Photo: Rulanzen Martin)

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept